Related Experiment Video
Updated: May 7, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Angina with "normal" coronary arteries: a changing philosophy
Raffaele Bugiardini1, C Noel Bairey Merz
1Department of Internal Medicine, Cardio-Angiology and Hepatology, University of Bologna, Bologna, Italy. raffaele.bugiardini@unibo.it
Women with angina and normal coronary arteries often have a serious condition. Their prognosis is not benign, and further cardiac event risk assessment and targeted therapies are crucial.
Area of Science:
- Cardiology
- Vascular Medicine
Background:
- Many women with angina receive a diagnosis of no significant heart disease despite normal coronary arteries.
- Reassurance is often the only treatment offered, potentially delaying necessary interventions.
Purpose of the Study:
- To review the diagnosis and therapy for angina in patients with normal or nonobstructive coronary arteries.
- To highlight the underappreciated prognosis and treatment strategies for this patient group.
Main Methods:
- Systematic literature search of MEDLINE and Cochrane Database of Systematic Reviews up to June 2004.
- Inclusion of reference lists and meeting presentations for comprehensive data.
- Keywords focused on angina diagnosis and therapy with normal angiography.
Main Results:
- Normal or nonobstructive coronary disease is common, especially in women with myocardial infarction.
- Patients with nonobstructive disease are more likely women and nonwhite, with symptoms indistinguishable from obstructive disease.
- A significant portion of women with normal angiography exhibit myocardial ischemia due to endothelial dysfunction, indicating increased future cardiac event risk.
Conclusions:
- Chest pain with normal angiograms predominantly affects women and carries a more serious prognosis than often assumed.
- Endothelial function assessment can identify patients at risk for future cardiac events.
- Therapies should include symptom relief (tricyclic agents, beta-blockers) and aggressive antiatherosclerotic treatment (statins, ACE inhibitors) based on risk factors.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Angina I: Introduction
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Angina IV: Management
Angina V: Nursing Management

